Today: 1 July 2026
Browse Category

ASX News 12 January 2026 - 19 January 2026

DroneShield shares jump after LAND 156 panel nod — what ASX:DRO investors watch next

DroneShield shares jump after LAND 156 panel nod — what ASX:DRO investors watch next

Sydney, Jan 15, 2026, 17:59 AEDT — After-hours Shares of DroneShield Ltd climbed on Thursday after the ASX-listed counter-drone equipment maker announced it had been selected for the Australian Defence Force’s LAND 156 Line of Effort 3 panel. The stock finished 2.77% higher at A$4.08, up from A$3.97 at the previous close, with the news coming at 4:37 p.m. local time. DroneShield is set to release its annual and preliminary results on Feb. 24, per its corporate calendar.
DroneShield stock closes higher after new-share filing; what ASX:DRO investors watch next

DroneShield stock closes higher after new-share filing; what ASX:DRO investors watch next

Sydney, Jan 13, 2026, 17:25 AEDT — Market closed. DroneShield Ltd has applied to list 500,000 new ordinary shares stemming from performance option exercises, according to an ASX filing. The shares were issued without any cash consideration, pushing the total ordinary shares on issue to 913,917,667. The stock closed 1.3% higher at A$3.90 on Tuesday.
Woodside Energy stock dips after Scarborough LNG milestone — what matters before the next ASX session

Woodside Energy stock dips after Scarborough LNG milestone — what matters before the next ASX session

Sydney, Jan 13, 2026, 17:31 AEDT — Trading after hours. Woodside Energy Group Ltd shares slipped 1.7% to close at A$23.31 on Tuesday, following news that the floating production unit for its Scarborough gas project reached the offshore field near Western Australia. The stock fluctuated between A$23.96 and A$23.28, with roughly 4.67 million shares trading hands.
1 6 7 8 9 10 13

Stock Market Today

  • Labcorp Holdings (LH) Looks Cheaper Than Charles River (CRL) on Key Metrics
    July 1, 2026, 1:17 PM EDT. Investors sizing up Medical Services stocks are comparing Labcorp Holdings (LH) and Charles River Laboratories (CRL) on value. LH has a better Zacks Rank #2 (Buy), while CRL sits at #3 (Hold), pointing to stronger earnings prospects for LH. The numbers give LH an edge: forward P/E ratio is 15.55 with a PEG ratio of 1.96, both lower than CRL's P/E of 20.53 and PEG at 2.59. LH's Price-to-Book is 2.64, ahead of CRL's 3.71. Zacks gives LH a Value grade of B; CRL gets a C. On these marks, LH looks like the better value pick right now.
Go toTop